+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The association of oropharyngeal and esophageal candidiasis in AIDS and its relation to the stage of immunodepression



The association of oropharyngeal and esophageal candidiasis in AIDS and its relation to the stage of immunodepression



Anales de Medicina Interna 9(11): 571-572




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041579166

Download citation: RISBibTeXText

PMID: 1467412


Related references

Association of esophageal candidiasis with acute hiv infection and the value of esophageal candidiasis as a diagnostic criterion for aids. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b228, 1992

Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS. Aids 9(5): 533-534, 1995

Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clinical Trials 1(1): 47-59, 2001

Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients. Annales de la Societe Belge de Medecine Tropicale 72(1): 45-52, 1992

Azole-resistant, progressive oropharyngeal and esophageal candidiasis in patients with AIDS A re-emerging indication for amphotericin B. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34: 213, 1994

Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870. Clinical Infectious Diseases 28(3): 587-596, 1999

Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest. Revista Medica de Chile 131(5): 515-519, 2003

Assessment of Therapeutic Response of Oropharyngeal and Esophageal Candidiasis in Aids with Use of a New Clinical Scoring System: Studies with D0870. Clinical Infectious Diseases 28(3): 587-596, 1999

Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer. Clinical Infectious Diseases 27(2): 283-286, 1998

Fluconazole vs Itraconazole-Flucytosine Association in the Treatment of Esophageal Candidiasis in AIDS Patients. Chest Journal 110(6): 1507-1514, 1996

AIDS and oropharyngeal candidiasis. Israel Journal of Dental Sciences 2(3): 162-166, 1989

Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. Journal of Infection 21(1): 55-60, 1990

Resistant oropharyngeal candidiasis in AIDS. Bailliere' s Clinical Infectious Diseases 3(1): 49-62, 1996

Role of posaconazole in the management of oropharyngeal and esophageal candidiasis. Therapeutics and Clinical Risk Management 3(4): 533-542, 2007

Management of oropharyngeal and esophageal candidiasis in patients with HIV infection. HIV Therapy 4(3): 325-343, 2010